Reducing Regulatory Red Tape for Pharmaceuticals

Health Canada has responded to Stakeholder concerns about timely access by patients to life-saving therapies by launching initiatives designed to improve market access. Adapt your market access strategy to the latest advances in regulatory reductions.  Take back to your team ideas to help you: 

• Understand how the Red Tape Review launched on July 9, 2025 could positively impact your market access plans 
• Navigate an increasingly flexible clinical trial environment 
• Analyze how the first Ministerial Reliance Order provides new submission opportunities 

Develop a roadmap for aligning your 2027 clinical and regulatory strategy with Canada’s increasingly agile and patient-centric approval landscape.